Pharyngitis
📧 Sign up to get email alerts when something new happens for Pharyngitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-06-12FDA Approved: CEFDINIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA has approved a supplemental application for cefdinir (Teva), updating the labeling for the product. This action confirms a labeling-rela…
-
FDA approval · 2008-06-11FDA Approved: CEFDINIR — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for CEFDINIR (cefdinir) from Lupin Pharmaceuticals, indicating an expanded approval for this antibio…
-
CLINICAL_TRIALS trial_result · 2008-04-24Clinical Trial Update: A Comparison Of Valdecoxib 20 Mg Twice Daily and 40 Mg Daily and Placebo In The Treatment Of Sore Throat [Phase 3]
Pfizer-sponsored Phase 3 trial comparing valdecoxib 20 mg twice daily, valdecoxib 40 mg daily, and placebo for pharyngitis has completed.
-
FDA approval · 2008-03-10FDA Approved: CEFPROZIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Cefprozil from Teva Pharmaceuticals USA, Inc., updating labeling or indications for the anti…
-
EMA withdrawal · 2008-02-14EMA Withdrawn: Levviax (telithromycin) — Aventis Pharma S.A.
Telithromycin (Levviax) has been withdrawn from the market by Aventis Pharma S.A. for community-acquired infections including pharyngitis, b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-01-16FDA Approved: CEFPROZIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for cefprozil from Lupin Pharmaceuticals, Inc., resulting in updated labeling under the supplemental…
-
FDA approval · 2008-01-07FDA Approved: CEFDINIR — Original Application (BluePoint Laboratories)
FDA approves an Abbreviated New Drug Application for cefdinir from BluePoint Laboratories, indicating the availability of a generic cefdinir…
-
FDA approval · 2007-12-14FDA Approved: CEFDINIR — Original Application (Aurobindo Pharma Limited)
FDA approved a generic cefdinir (CEFDINIR) from Aurobindo Pharma Limited under an Original Application (ANDA) for acute otitis media, acute …
-
FDA approval · 2007-10-17FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Clarithromycin submitted by Sandoz Inc, granting a supplemental approval for the product.
-
FDA approval · 2007-09-07FDA Approved: CEFDINIR — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for cefdinir, updating the approved labeling for the product.
-
FDA approval · 2007-08-20FDA Approved: CLARITHROMYCIN — Original Application (Chartwell RX, LLC.)
FDA approved a generic version of clarithromycin from Chartwell RX, LLC through an Original Abbreviated New Drug Application (ANDA).
-
FDA approval · 2007-07-25FDA Approved: CEPHALEXIN — Original Application (Chartwell RX, LLC)
FDA approved an Original Application for generic Cephalexin by Chartwell RX, LLC, adding a generic option for this antibiotic.
-
FDA approval · 2007-05-07FDA Approved: CEFDINIR — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for CEFDINIR, a generic cefdinir product, authorizing continued/expanded ma…
-
FDA approval · 2007-05-04FDA Approved: CEFDINIR — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's original application for CEFDINIR (cefdinir), a generic cephalosporin antibiotic.
-
FDA approval · 2007-03-26FDA Approved: AMOXICILLIN — Original Application (Sandoz Inc)
FDA approved Sandoz Inc's original application for amoxicillin, making a generic amoxicillin product available. The approval supports its us…
-
FDA approval · 2007-01-30FDA Approved: CEFPROZIL — Original Application (Aurobindo Pharma Limited)
The FDA approved the original application for cefprozil from Aurobindo Pharma Limited, making a generic cephalosporin antibiotic available i…
-
CLINICAL_TRIALS trial_result · 2006-12-08Clinical Trial Update: APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) for 10 Days in Patients With Strep Throat [Phase 3]
A Phase 3 trial comparing APC-111 administered once daily for 7 days to penicillin four times daily for 10 days in patients with strep throa…
-
CLINICAL_TRIALS trial_result · 2006-10-25Clinical Trial Update: APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat [Phase 3]
Phase 3 trial comparing APC-111 MP Tablet once daily versus Penicillin VK four times daily for 10 days in patients with streptococcal pharyn…
-
CLINICAL_TRIALS trial_result · 2006-08-29Clinical Trial Update: A Trial of Point of Care Information in Ambulatory Pediatrics [Phase 3]
A Phase 3 clinical trial evaluating a point-of-care information tool in ambulatory pediatrics has completed.
-
FDA approval · 2006-06-19FDA Approved: AMOXICILLIN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc. to market amoxicillin under an Original Application (ANDA). The approval covers a generic amoxic…
-
FDA approval · 2006-05-19FDA Approved: CEFDINIR — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin's generic cefdinir (CEFDINIR) under an Original Application (ANDA065264), providing a new generic cephalosporin option.